Quick Comparison
| Magnesium Glycinate | Phosphatidylserine | |
|---|---|---|
| Half-Life | 12-17 hours | Not well-characterized orally; brain PS turns over slowly |
| Typical Dosage | Standard: 200-400 mg elemental magnesium daily (note: magnesium glycinate is ~14% elemental magnesium by weight, so 2000 mg magnesium glycinate provides ~280 mg elemental). Take in the evening for sleep benefits. Can be split into 2 doses. | Standard: 100-300 mg daily in 1-3 doses. Most studies use 300 mg daily. Soy-derived and sunflower-derived forms are both effective. Take with food for absorption. |
| Administration | Oral (capsules, powder, tablets). Well-tolerated. Take with or without food. | Oral (softgels, capsules). Soy-derived or sunflower-derived. Take with fat for absorption. |
| Research Papers | 8 papers | 10 papers |
| Categories |
Mechanism of Action
Magnesium Glycinate
Magnesium is required for over 300 enzymatic reactions including neurotransmitter synthesis (tyrosine hydroxylase, tryptophan hydroxylase), energy production (ATPases, kinases, glycolytic enzymes), and DNA repair (PARP, DNA polymerases). In the brain, magnesium blocks NMDA receptors at the voltage-dependent Mg2+ binding site within the channel pore (GluN1/GluN2 subunits), preventing excessive calcium influx and excitotoxicity — Mg2+ is displaced only upon depolarization and glycine/glutamate binding. The glycine component activates inhibitory glycine receptors (GlyR alpha1/alpha2) in the brainstem and spinal cord, and serves as an obligatory co-agonist at the GluN1 glycine site of NMDA receptors. Glycine also modulates NMDA receptor function. Together, magnesium and glycine produce calming effects through complementary inhibitory mechanisms: reduced glutamatergic excitability and enhanced inhibitory neurotransmission.
Phosphatidylserine
PS is a structural component of neuronal membranes, maintaining membrane fluidity and supporting receptor function, ion channel activity, and neurotransmitter release. It localizes preferentially to the inner leaflet of the plasma membrane via flippase enzymes (P4-ATPases), where it serves as a cofactor for protein kinase C (PKC) isoforms alpha, beta, and gamma — PKC activation phosphorylates substrates including MARCKS and GAP-43, critical for synaptic plasticity and memory consolidation. PS modulates the HPA axis via glucocorticoid receptor feedback, reducing cortisol by 15-30% in stressed individuals. It facilitates choline transport via high-affinity choline transporter (CHT1) into presynaptic terminals, supporting acetylcholine synthesis by choline acetyltransferase. PS also regulates NMDA receptor function and supports Na+/K+-ATPase activity. Downstream, PS enhances CREB phosphorylation and BDNF expression in hippocampal neurons.
Risks & Safety
Magnesium Glycinate
Common
Mild drowsiness (often desired), loose stools at high doses (less than with other forms).
Serious
Avoid high doses with kidney impairment.
Rare
Diarrhea, nausea.
Phosphatidylserine
Common
Mild gastrointestinal discomfort, insomnia at high doses.
Serious
May interact with blood thinners.
Rare
Allergic reaction in soy-sensitive individuals (use sunflower-derived).
Full Profiles
Magnesium Glycinate →
A highly bioavailable form of magnesium chelated with glycine. The glycine component adds its own calming effects (inhibitory neurotransmitter), making this form particularly effective for anxiety, sleep, and stress. Better tolerated than magnesium citrate or oxide with fewer GI side effects. Magnesium deficiency affects an estimated 50-80% of adults and directly impairs cognitive function.
Phosphatidylserine →
A phospholipid that constitutes 15% of the brain's total phospholipid pool and is concentrated in neuronal cell membranes. Phosphatidylserine (PS) supports memory, cognitive function, and cortisol regulation. It is the only nootropic with an FDA-qualified health claim: 'consumption may reduce the risk of cognitive dysfunction in the elderly.' Particularly effective for age-related cognitive decline.